By the end of this BC ECHO on Substance Use session, participants will be able to:
1) describe the evidence for iOAT in treating opioid use disorder,
2) incorporate iOAT as part of the continuum of care for opioid use disorder,
3) evaluate patients for initiating iOAT, and
4) safely initiate and titrate iOAT, and provide ongoing clinical support to a patient on iOAT.